The simplicity of assessing HGDSs, TBs, and DR during routine histopathological tests using operative specimens of CRC, along with the routine evaluation of preoperative serum CEA levels in many hospitals, makes this grading system easily adaptable to daily clinical practice in treating CRC patients. The gene discussed is CEACAM5; the disease is colorectal carcinoma.